CJC-1295 (without DAC) Peptide research-grade
CJC-1295 (without DAC) Peptide
$39.00 $86.00Price range: $39.00 through $86.00 Select options

CJC-1295 (without DAC) Peptide

Price range: $39.00 through $86.00

Laboratory-grade CJC-1295 (without DAC) Peptide is a modified GHRH analog used in short-acting growth hormone–axis laboratory studies. Research buyers select this listing for pre-clinical work on GHRH receptor signaling and controlled peptide pulse models—not for clinical, veterinary, or consumer use.

For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

CJC-1295 (without DAC) Peptide research-grade

Overview

Laboratory-grade CJC-1295 (without DAC) Peptide presents as a modified GHRH analog used in short-acting growth hormone–axis laboratory studies. Nationwide lists this SKU for controlled research programs focused on GHRH receptor signaling and controlled peptide pulse models—not for clinical, veterinary, or consumer use.

Research buyers specify CJC-1295 (without DAC) Peptide when protocols require a characterized input for GHRH receptor signaling and controlled peptide pulse models. Typical deployments include cell-based or cell-free assays, method development plates, and pathway-mapping models executed under institutional laboratory SOPs.

The catalog record supports pre-clinical documentation trails across replicates and partner sites. Archive shipment paperwork with study files whenever CJC-1295 (without DAC) Peptide enters a new experimental series.

Research Context for CJC-1295 (without DAC) Peptide

Work involving CJC-1295 (without DAC) Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of CJC-1295 (without DAC) Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source CJC-1295 (without DAC) Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with CJC-1295 (without DAC) Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using CJC-1295 (without DAC) Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of CJC-1295 (without DAC) Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 9 PubMed records. Displaying 10 per page.

  1. Teichman SL et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I… [PMID: 16352683]

    Laboratory literature summary: Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Van Hout MC et al. (2016). Netnography of research models Use of the Synthetic Growth Hormone CJC-1295: Pulses… [PMID: 26771670]

    Laboratory literature summary: Netnography of research models Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Timms M et al. (2019). A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS [PMID: 30938069]

    Laboratory literature summary: A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Timms M et al. (2019). An immuno polymerase chain reaction screen for the detection of CJC-1295 and other… [PMID: 30489688]

    Laboratory literature summary: An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Alba M et al. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone… [PMID: 16822960]

    Laboratory literature summary: Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Ionescu M et al. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by… [PMID: 17018654]

    Laboratory literature summary: Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Henninge J et al. (2010). Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown… [PMID: 21204297]

    Laboratory literature summary: Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Jetté L et al. (2005). Research subjects growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates… [PMID: 15817669]

    Laboratory literature summary: research subjects growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Sackmann-Sala L et al. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in… [PMID: 19386527]

    Laboratory literature summary: Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight.125 lbs
Dimensions9 × 7 × .5 in
Size: No selection

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is CJC-1295 peptide?

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It is studied in research laboratories for its role in growth hormone signaling and receptor-related pathways.

What is CJC-1295 used for in research?

CJC-1295 is used in research laboratories to investigate endocrine signaling, peptide-receptor interactions, and growth hormone pathway activity. It is not approved for human use.

Is CJC-1295 (without DAC) Peptide approved or intended for human use?

No. CJC-1295 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is CJC-1295 (without DAC) Peptide FDA-approved for medical or clinical use?

No. CJC-1295 is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is CJC-1295 supplied?

CJC-1295 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should CJC-1295 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for CJC-1295?

CJC-1295 is available in multiple vial sizes.

Is CJC-1295 (without DAC) Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is CJC-1295 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://nationwidepeptides.com/shipping-and-payments

How can I verify CJC-1295 purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://nationwidepeptides.com/coa/